Meetings and events

15

Mar, 2019

CROI 2019: Oral presentation by members of the EPIICAL team

Tags: , ,

The annual Conference on Retroviruses and Opportunistic Infections (CROI) was held on 4-7 March 2019, at the Washington State Convention Center in Seattle, Washington. At this year’s event, EPIICAL team member Sara Dominguez Rodriguez delivered an engaging oral presentation on the earliest antiretroviral therapy initiation in infants.

READ MORE

1

Mar, 2019

CROI: Members of the EPIICAL team to attend in Seattle

Tags: , , ,

Seattle is gearing up for the 2019 edition of CROI next week. Held at Washington State Convention Center on 4th-7th March, the Conference on Retroviruses and Opportunistic Infections is an important event in the Penta calendar, and in particular for the EPIICAL consortium, as it is an opportunity for members to discuss the latest developments pertaining to the project. Included on the agenda, EPIICAL project researchers will make an oral presentation illustrating recent results that provide further evidence that supports the earliest ART initiation in infants.

READ MORE

20

Nov, 2018

The EPIICAL 2nd General Assembly was a fabulous success!

Tags:

Held at the Hospital General Universitario Gregorio Marañón on 14th to 16th November 2018, the 2nd EPIICAL General Assembly welcomed around 50 scientists and healthcare professionals working together to establish new scientific efforts leading to HIV remission in children.

READ MORE

21

May, 2018

EARTH: first patient has been recruited!

Tags: , , ,

It is with great pleasure that we announce that the first patient in the EARTH study has been recruited. This encouraging news comes to us from the PHRU site in Soweto, South Africa. Now that all sites are open for recruitment, with some patients having already been screened, we are confident we will see more participants in the near future. This is the first of 150 children to be enrolled from one of 5 sites situated in South Africa and Mozambique. The EARTH project, nested within the EPIICAL platform, is a prospective multicentre, low-interventional study of HIV+ perinatally […]

READ MORE